COR

Coresite Realty Corporation
COR

Delisted

COR was delisted on the 27th of December, 2021.

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 35.7%
Negative

Neutral
Business Wire
yesterday
IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--IntrinsiQ® Specialty Solutions (IntrinsiQ), a leader in data analytic solutions, and part of Cencora, can now offer expanded data and insights for oncology, retina and other therapeutic areas. As part of this expansion, IntrinsiQ is now also offering oncology biomarker data, enabling physicians to transition from a generalized treatment approach to precision medicine. This critical data allows physicians to tailor cancer therapies to the individual needs of e.
IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes
Negative
Barrons
3 days ago
The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.
Those looking to buy stocks right now should look for the ones that aren't correlated to the artificial intelligence trade.
The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.
Positive
Zacks Investment Research
4 days ago
Here's Why Cencora (COR) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Cencora (COR) is a Strong Growth Stock
Neutral
Business Wire
11 days ago
Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2025 on Wednesday, November 5, 2025, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 5, 2025. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President &.
Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release
Positive
Zacks Investment Research
21 days ago
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Positive
Zacks Investment Research
25 days ago
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
Neutral
Seeking Alpha
1 month ago
Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Cencora, Inc. (NYSE:COR ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 11:30 AM EDT Company Participants James Cleary - Executive VP & CFO Bennett Murphy - Senior VP, Head of Investor Relations & Treasury Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Good afternoon, everyone. Welcome to Day 3 of the Morgan Stanley Healthcare Conference.
Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Neutral
Seeking Alpha
1 month ago
Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript
Cencora, Inc. (NYSE:COR ) Baird Global Healthcare Conference 2025 September 9, 2025 3:45 PM EDT Company Participants Bennett Murphy - Senior VP, Head of Investor Relations & Treasury James Cleary - Executive VP & CFO Conference Call Participants Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division Presentation Eric Coldwell Senior Research Analyst All right.
Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript
Neutral
Seeking Alpha
1 month ago
Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Cencora, Inc. (NYSE:COR ) Wells Fargo 20th Annual Healthcare Conference 2025 September 5, 2025 8:45 AM EDT Company Participants James Cleary - Executive VP & CFO Bennett Murphy - Senior VP, Head of Investor Relations & Treasury Conference Call Participants Stephen Baxter - Wells Fargo Securities, LLC, Research Division Presentation Stephen Baxter Senior Equity Analyst All right. Good morning, everyone.
Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Neutral
Zacks Investment Research
1 month ago
Here's Why You Should Hold Cencora Stock in Your Portfolio Now
COR gains from strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose risks.
Here's Why You Should Hold Cencora Stock in Your Portfolio Now